Across TCGA pan-cancer cohorts, DNAJB1P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DNAJB1P1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where DNAJB1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJB1P1 is over-expressed in tumor, although a few such as BLCA and THCA show the opposite, repressed pattern.

LIHC, LUSC, and BLCA are the cancer types where DNAJB1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJB1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.334	.006	5	view →
LUSC	All	All	+0.041	.012	3	view →
BLCA	Female	All	−0.131	.032	2	view →
THCA	All	All	−0.073	.012	2	view →
COAD	All	All	+0.069	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: DNAJB1P1 RNA expression & survival · all DNAJB1P1 data types